SAKK at the European Society for Medical Oncology (ESMO) Congress 2022

The following SAKK trials were presented at this year’s ESMO Congress held in Paris from September 9-13, 2022.

SAKK at the European Society for Medical Oncology (ESMO) Congress 2022

The following SAKK trials were presented at this year’s ESMO Congress held in Paris from September 9-13, 2022.
PD Dr. med.
Christian
Rothermundt
SAKK 08/14, Presentation ESMO 2022

SAKK 08/14, Presentation ESMO 2022

SAKK 08/14 - IMPROVE Investigation of metformin in patients with castration resistant prostate cancer in combination with enzalutamide vs. enzalutamide alone. A randomized, open label, phase II trial
Dr. med.
Sara
Bastian
Coordinating Investigator
SAKK 41/16, Poster ESMO 2022

SAKK 41/16, Poster ESMO 2022

Neoadjuvant treatment with regorafenib and capecitabine combined with radiotherapy in locally advanced rectal cancer: A multicenter phase Ib trial (RECAP) SAKK 41/16
Dre MSc
Antonia
Digklia
SAKK 57/16, Poster ESMO 2022

SAKK 57/16, Poster ESMO 2022

SAKK 57/16 nab-paclitaxel and gemcitabine in soft tissue sarcoma (NAPAGE): Final results from the phase Ib/II trial with >2y median follow up
All News